Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(9%)
Results Posted
38%(3 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
1
9%
Ph phase_3
3
27%
Ph phase_1
2
18%
Ph not_applicable
2
18%
Ph phase_2
2
18%

Phase Distribution

2

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 22 (20.0%)
Phase 33 (30.0%)
Phase 41 (10.0%)
N/A2 (20.0%)

Trials by Status

recruiting19%
terminated19%
unknown19%
completed873%

Recent Activity

1 active trials
Showing 5 of 11
completed

A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

NCT07234318
recruitingphase_2

Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes

NCT05153070
completedphase_1

Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects

NCT04788641
completednot_applicable

Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery

NCT05691764
terminatedphase_2

Stem Cell Transplantation for Metastatic Solid Tumors

NCT00001880
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07234318

A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

Completed
NCT05153070Phase 2

Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes

Recruiting
NCT04788641Phase 1

Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects

Completed
NCT05691764Not Applicable

Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery

Completed
NCT00001880Phase 2

Stem Cell Transplantation for Metastatic Solid Tumors

Terminated
NCT04597762Not Applicable

Effect of Ciclosporin Eyedrops on Sjögren Syndrome

Completed
NCT00426101Phase 3

Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004

Completed
NCT00296296Phase 4

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

Completed
NCT03180723Phase 3

Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis

Unknown
NCT00135811Phase 3

Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)

Completed
NCT00705120Phase 1

Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11